Alaunos Therapeutics (TCRT) Times Interest Earned (2011 - 2026)
Alaunos Therapeutics' (TCRT) quarterly Times Interest Earned came in at -$53.26 in Q1 2026, up 46.15% on a QoQ basis from -$98.92 in Q3 2025.
Alaunos Therapeutics (TCRT) Times Interest Earned (2011 - 2026) Analysis & Trends
Alaunos Therapeutics (TCRT) has 15 years of Times Interest Earned data on file, last reported at -$53.26 in Q1 2026.
- Quarterly Times Interest Earned changed N/A year-over-year to -$53.26 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$218.16 (down 644.14% YoY) and the FY2025 annual result came in at -$0.02, changed N/A from the prior year.
- Times Interest Earned rose to -$53.26 in Q1 2026, from -$98.92 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of -$0.02 in Q2 2025 to a low of -$98.92 in Q3 2025.
- A 4-year average of -$27.14 and a median of -$11.61 in 2022 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2022 — Times Interest Earned soared 79.43% — and 2023, when it sank 491.26%.
- Tracing TCRT's Times Interest Earned over 4 years: stood at -$9.47 in 2022, then slumped by 491.26% to -$55.98 in 2023, then sank by 76.7% to -$98.92 in 2025, then jumped by 46.15% to -$53.26 in 2026.
- The last three Times Interest Earned figures came in at -$53.26 (Q1 2026), -$98.92 (Q3 2025), and -$0.02 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Alaunos Therapeutics | 4.28 Mn | 4.16 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -53.26 |
| Sep 30, 2025 | -98.92 |
| Jun 30, 2025 | -0.02 |
| Dec 31, 2023 | -55.98 |
| Jun 30, 2023 | -7.26 |
| Mar 31, 2023 | -10.75 |
| Dec 31, 2022 | -9.47 |
| Sep 30, 2022 | -10.33 |
| Jun 30, 2022 | -12.48 |
| Mar 31, 2022 | -12.98 |
| Dec 31, 2021 | -14.62 |
| Sep 30, 2021 | -50.22 |
| Jun 30, 2021 | -19.42 |
| Mar 31, 2021 | -4.38 |
| Dec 31, 2020 | -168.70 |
| Sep 30, 2020 | -6.44 |
| Jun 30, 2020 | -6.42 |
| Mar 31, 2020 | -21.60 |
| Dec 31, 2019 | -80.18 |
| Sep 30, 2019 | -2.23 |